Kevan L. Hartshorn
Director of the Hematology/Oncology Fellowship Program · Chobanian and Avedisian School of Medicine
Credentials: · · · ·
History
- Present
Hematology/Oncology Fellowship · Chobanian and Avedisian School of Medicine
Research
Recombinant human interferon alfa-A suppresses HTLV-III replication in vitro
The Lancet · 1985 · 339 citations
Evidence for a protective role of pulmonary surfactant protein D (SP-D) against influenza A viruses
Journal of Clinical Investigation · 1994 · First of 7 authors · 267 citations
Ribavirin antagonizes the effect of azidothymidine on HIV replication
Science · 1987 · 252 citations
50 papers
19 papers
- MH
9 papers
9 papers
5 papers
5 papers
- SL
5 papers · 3 as a fellow
4 papers
Grants
- 2001–2020
Enhancing Collectin Mediated Defense Against Influenza
National Heart, Lung, and Blood Institute · R01
Contact PI · $6.6M · Boston Medical Center
- 1998–2003
Enhancing Collectin Mediated Host Defense
National Heart, Lung, and Blood Institute · R01
Contact PI · $1M · Boston University Medical Campus
- 1995–1999
Neutrophil Activation by Viruses and Mammalian Lectins
National Institute of Allergy and Infectious Diseases · R01
Contact PI · $596.2K · Boston University Medical Campus
- 1990–1995
Novel Viral Probe of Neutrophil Activation
National Institute of Allergy and Infectious Diseases · R29
Contact PI · $592.1K · Boston University Medical Campus
Clinical trials
- 2013
Study of Panitumumab in the Treatment of Carcinoid Syndrome
Principal investigator · Withdrawn · Phase 2
Boston Medical Center